These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27583702)

  • 1. Stability study of oral pediatric idebenone suspensions.
    Schlatter J; Bourguignon E; Majoul E; Kabiche S; Balde IB; Cisternino S; Fontan JE
    Pharm Dev Technol; 2017 Mar; 22(2):296-299. PubMed ID: 27583702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of extemporaneously prepared cinacalcet oral suspensions.
    Thomson K; Hutchinson DJ; Chablani L
    Am J Health Syst Pharm; 2018 May; 75(9):e236-e240. PubMed ID: 29691267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of extemporaneously prepared glycopyrrolate oral suspensions.
    Cober MP; Johnson CE; Sudekum D; Penprase K
    Am J Health Syst Pharm; 2011 May; 68(9):843-5. PubMed ID: 21515869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of extemporaneously prepared oxandrolone oral suspensions.
    Johnson CE; Cober MP; Hawkins KA; Julian JD
    Am J Health Syst Pharm; 2011 Mar; 68(6):519-21. PubMed ID: 21378300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of an extemporaneous alcohol-free melatonin suspension.
    Johnson CE; Cober MP; Thome T; Rouse E
    Am J Health Syst Pharm; 2011 Mar; 68(5):420-3. PubMed ID: 21330684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of extemporaneously prepared rifaximin oral suspensions.
    Cober MP; Johnson CE; Lee J; Currie K
    Am J Health Syst Pharm; 2010 Feb; 67(4):287-9. PubMed ID: 20133533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of extemporaneously prepared moxifloxacin oral suspensions.
    Hutchinson DJ; Johnson CE; Klein KC
    Am J Health Syst Pharm; 2009 Apr; 66(7):665-7. PubMed ID: 19299374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of Extemporaneously Prepared Hydroxycarbamide Oral Suspensions.
    Kabiche D; Balde IB; Majoul E; Kabiche S; Bourguignon E; Fontan JE; Cisternino S; Schlatter J
    Int J Pharm Compd; 2017; 21(2):160-163. PubMed ID: 28346212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and Stability Study of Eslicarbazepine Acetate Oral Suspensions for Extemporaneous Compounding.
    Zhao F; Dave VS; Mar MZ; Perri JR
    Int J Pharm Compd; 2018; 22(5):433-439. PubMed ID: 30384342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of an extemporaneously prepared alcohol-free phenobarbital suspension.
    Cober MP; Johnson CE
    Am J Health Syst Pharm; 2007 Mar; 64(6):644-6. PubMed ID: 17353574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of extemporaneously prepared rufinamide oral suspensions.
    Hutchinson DJ; Liou Y; Best R; Zhao F
    Ann Pharmacother; 2010 Mar; 44(3):462-5. PubMed ID: 20150505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temozolomide stability in extemporaneously compounded oral suspensions.
    Trissel LA; Zhang Y; Koontz SE
    Int J Pharm Compd; 2006; 10(5):396-9. PubMed ID: 23974320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of extemporaneously prepared sodium phenylbutyrate oral suspensions.
    Caruthers RL; Johnson CE
    Am J Health Syst Pharm; 2007 Jul; 64(14):1513-5. PubMed ID: 17617502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Extemporaneously Compounded Aripiprazole Oral Suspensions for Use in Children.
    Pramann LA; Davidow LW; van Haandel L; Funk RS
    Int J Pharm Compd; 2016; 20(3):257-261. PubMed ID: 28333668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of dolasetron in two oral liquid vehicles.
    Johnson CE; Wagner DS; Bussard WE
    Am J Health Syst Pharm; 2003 Nov; 60(21):2242-4. PubMed ID: 14619116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of extemporaneous erlotinib, lapatinib, and imatinib oral suspensions.
    Li Q; Liu Z; Kolli S; Wetz K; Griffith N; Poi MJ
    Am J Health Syst Pharm; 2016 Sep; 73(17):1331-7. PubMed ID: 27543577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of an extemporaneously prepared thalidomide suspension.
    Kraft S; Johnson CE; Tyler RP
    Am J Health Syst Pharm; 2012 Jan; 69(1):56-8. PubMed ID: 22180553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of lamotrigine in two extemporaneously prepared oral suspensions at 4 and 25 degrees C.
    Nahata MC; Morosco RS; Hipple TF
    Am J Health Syst Pharm; 1999 Feb; 56(3):240-2. PubMed ID: 10030509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naratriptan hydrochloride in extemporaneosly compounded oral suspensions.
    Zhang YP; Trissel LA; Fox JL
    Int J Pharm Compd; 2000; 4(1):69-71. PubMed ID: 23985892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of nifedipine in two oral suspensions stored at two temperatures.
    Nahata MC; Morosco RS; Willhite EA
    J Am Pharm Assoc (Wash); 2002; 42(6):865-7. PubMed ID: 12482010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.